These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9883921)

  • 41. Progestogens in cardiovascular diseases: an introduction to the epidemiologic data.
    Mann JI
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):752-7. PubMed ID: 7065056
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemiology of oral contraceptives and cardiovascular disease.
    Chasan-Taber L; Stampfer MJ
    Ann Intern Med; 1998 Mar; 128(6):467-77. PubMed ID: 9499331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Women's knowledge of taking oral contraceptive pills correctly and of emergency contraception: effect of providing information leaflets in general practice.
    Smith LF; Whitfield MJ
    Br J Gen Pract; 1995 Aug; 45(397):409-14. PubMed ID: 7576845
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of changes in smoking status on risk estimates for myocardial infarction among women recruited for the Royal College of General Practitioners' Oral Contraception Study in the UK.
    Owen-Smith V; Hannaford PC; Warskyj M; Ferry S; Kay CR
    J Epidemiol Community Health; 1998 Jul; 52(7):420-4. PubMed ID: 9799875
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study.
    Iversen L; Fielding S; Lidegaard Ø; Mørch LS; Skovlund CW; Hannaford PC
    BMJ; 2018 Sep; 362():k3609. PubMed ID: 30257920
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of low-dose oral contraceptives and stroke in young women.
    Schwartz SM; Siscovick DS; Longstreth WT; Psaty BM; Beverly RK; Raghunathan TE; Lin D; Koepsell TD
    Ann Intern Med; 1997 Oct; 127(8 Pt 1):596-603. PubMed ID: 9341057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 30 years of change: the current perspective on cardiovascular risks and oral contraceptives.
    Contracept Rep; 1995 May; 6(2):4-9, 14. PubMed ID: 12319497
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Further insight gained on impact of OC use.
    Contracept Technol Update; 1999 Apr; 20(4):43-4. PubMed ID: 12295066
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combined oral contraceptives and liver disease.
    Hannaford PC; Kay CR; Vessey MP; Painter R; Mant J
    Contraception; 1997 Mar; 55(3):145-51. PubMed ID: 9115002
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Absence of correlation between oral contraceptive usage and cardiovascular mortality.
    Wiseman RA
    Int J Fertil; 1984; 29(4):198-208. PubMed ID: 6152441
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The oral contraceptive user.
    Lidegaard O; Overgaard K; Hauch O
    Acta Obstet Gynecol Scand; 1988; 67(1):27-31. PubMed ID: 3176910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral contraceptives and gallbladder disease. Royal College of General Practitioners' oral contraception study.
    Lancet; 1982 Oct; 2(8305):957-9. PubMed ID: 6127462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of the October 1995 pill scare in Grampian.
    Flett G; Gurney E; McKessock L; Reid J
    Br J Fam Plann; 1998 Apr; 24(1):18-20. PubMed ID: 9719702
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1996 Aug; 348(9026):498-505. PubMed ID: 8757151
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Further analyses of mortality in oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study.
    Lancet; 1981 Mar; 1(8219):541-6. PubMed ID: 6111642
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined oral contraceptives containing chlormadinone acetate and breast cancer: results of a case-control study.
    Ebeling K; Ray R; Nischan P; Thomas DB; Kunde D; Stalsberg H
    Br J Cancer; 1991 May; 63(5):804-8. PubMed ID: 1710136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Venous thromboembolism and desogestrel- or gestodene-containing combination oral contraceptives: what are the facts?
    Contracept Rep; 1996 Apr; 7(1):3-6. PubMed ID: 12320047
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral contraceptives and malignant melanoma.
    Hannaford PC; Villard-Mackintosh L; Vessey MP; Kay CR
    Br J Cancer; 1991 Mar; 63(3):430-3. PubMed ID: 2003986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.